Impact of Unrestrictive Exercise Following Mid-Urethral Sling Surgery

Sponsor
Cedars-Sinai Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT02316275
Collaborator
(none)
50
1
2
240
0.2

Study Details

Study Description

Brief Summary

To determine the impact of unrestricted postoperative activity on intermediate- and long-term continence outcomes of mid-urethral sling surgery in women with stress urinary incontinence.

To assess the natural return to baseline activity level when patients are unrestricted following mid-urethral sling surgery with or without concomitant anterior or posterior pelvic organ prolapse repair.

Condition or Disease Intervention/Treatment Phase
  • Other: No post-operative activity restrictions
  • Other: Standard post-operative activity restriction
N/A

Detailed Description

Over the last decade, the mid-urethral sling has become the new gold standard in the management of stress urinary incontinence because of its high success rate and minimally invasive nature. However, postoperative management has not kept pace with the modernization of sling surgery. Although formal guidelines regarding the resumption of normal activity levels have not been established, it is general practice to restrict exercise for a minimum of six weeks after surgery.

For the study, if immediate resumption of normal activity has no impact on intermediate- and long-term continence outcomes, it may result in improved quality of life and cost savings from a societal perspective.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
IMpact of Unrestricted ACTIVity Following Mid-Urethral Sling Surgery (I'M ACTIVe): Quality of Life and Cost Implications
Study Start Date :
Dec 1, 2011
Anticipated Primary Completion Date :
Dec 1, 2021
Anticipated Study Completion Date :
Dec 1, 2031

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Standard post-operative activity restriction

As a traditional method, patients will be restricted from activity for six weeks after sling surgery.

Other: Standard post-operative activity restriction

Experimental: No post-operative activity restrictions

Patients are to resume regular activity immediately after mid-urethral sling surgery.

Other: No post-operative activity restrictions
Patients are to resume regular activity immediately after mid-urethral sling surgery. The investigators will determine the impact of unrestricted post-operative activity on continence outcomes of mid-urethral sling surgery in women with stress urinary incontinence (SUI). Investigators will measure the effect of unrestricted post-operative activity on early health-related quality of life (HRQOL). A Productivity Loss form for cost-effective analysis will be asked of the patient.

Outcome Measures

Primary Outcome Measures

  1. Unrestricted postoperative physical activity for surgical outcomes measure by questionnaire assessment. [2 years]

    Return to normal activity immediately after mid-urethral sling surgery could result in faster return to baseline health-related quality of life. Each questionnaire will be administered weekly following surgery until the patient returns to within 10% of baseline scores. Cost-effectiveness of early return to normal activity via Productivity Loss form as time spent recovering from surgery will be analyzed (incremental cost effectiveness ratio of net means by comparing the unrestricted and restricted groups).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Non-pregnant female

  • Self-reported stress urinary incontinence

  • Incontinence demonstrated on physical exam and/or by an urodynamics study

  • Planned mid-urethral sling surgery

  • Available for 2 years of follow-up

  • Willing and able to complete study assessments per the judgment of the treating clinician

  • Willing and able to provide written informed consent

Exclusion Criteria:
  • Age <18 years at time of enrollment

  • Concomitant prolapse surgery other than anterior colporrhaphy

  • Currently pregnant or <12 months post-partum

  • Unable to read, write, or comprehend English

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cedars-Sinai Medical Center Beverly Hills California United States 90211

Sponsors and Collaborators

  • Cedars-Sinai Medical Center

Investigators

  • Principal Investigator: Jennifer Anger, MD, MPH, Cedars-Sinai Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Jennifer T. Anger, Principal Investigator, Cedars-Sinai Medical Center
ClinicalTrials.gov Identifier:
NCT02316275
Other Study ID Numbers:
  • Pro00026474
First Posted:
Dec 12, 2014
Last Update Posted:
Jul 18, 2018
Last Verified:
Jul 1, 2018
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 18, 2018